Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-13T06:53:26.892Z Has data issue: false hasContentIssue false
  • English
  • Français

Infection Rates in Standard vs. Hydrogel Coated Ventricular Catheters

Published online by Cambridge University Press:  02 December 2014

Anthony M. Kaufmann ,
Tara Lye ,
Gary Redekop ,
Angela Brevner ,
Mark Hamilton ,
Michelle Kozey  and
David Easton
Anthony M. Kaufmann
Affiliation:
Section of Neurosurgery, University of Manitoba, Manitoba, MB, Canada
Tara Lye
Affiliation:
Community Health Sciences, University of Calgary, Calgary, AB, Canada
Gary Redekop
Affiliation:
Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada
Angela Brevner
Affiliation:
Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada
Mark Hamilton
Affiliation:
Division of Neurosurgery, University of Calgary, Calgary, AB, Canada
Michelle Kozey
Affiliation:
Section of Neurosurgery, University of Manitoba, Manitoba, MB, Canada
David Easton
Affiliation:
Calgary Laboratory Services, Calgary, AB, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Infection related to external ventricular drain (EVD) use is a common neurosurgical complication. Modified catheters with a hydrophilic surface may impede bacterial adherence and thereby reduce catheter related cerebrospinal fluid (CSF) infection.

Methods:

A prospective randomized clinical trial compared the occurrence of CSF infection related to use of either standard silastic or hydrogel coated EVD catheters (Bioglide®, Medtronic). Enrolment was available to all adult neurosurgery patients undergoing placement of a first EVD, at three university centers. The catheters were presoaked in a low concentration of bacitracin solution for 5-10 minutes prior to insertion. Bacterial infection was defined by heavy growth in a single CSF sample or light / medium growth in two consecutive samples. A secondary analysis was also conducted for “probable” CSF infection, including patients started on antibiotics after light / medium growth in a single CSF sample. Statistical analyses included Kaplan-Meier survival curve estimates accompanied by Log Rank and Breslow tests.

Results:

There were 158 randomized patients available to assess for EVD related infection of CSF. The two study groups had similar clinical characteristics including average duration of EVD use (8±4 days). Definite CSF infection occurred in seven and probable infection in another six (8% total). Infection incidence rose steadily from day 2 (1%) to day 11 (11%). There was no difference of daily occurrence of EVD infection between the two catheter types.

Conclusion:

Infection remains a common hazard in the use of EVD, and we found no reduction of infection using the hydrogel-coated catheters when presoaked in low concentration bacitracin solution.

Type
Other
Information
Canadian Journal of Neurological Sciences , Volume 31 , Issue 4 , November 2004 , pp. 506 - 510
Copyright
Copyright © The Canadian Journal of Neurological 2004

References

1. Ohrstrom, JK, Skou, JK, Ejlertsen, T, Kosteljanetz, M. Infected ventriculostomy: bacteriology and treatment. Acta Neurochir (Wien) 1989; 100(1-2):67–69.CrossRefGoogle ScholarPubMed
2. Horan, TC, Gaynes, RP, Martone, WJ, Jarvis, WR, Emori, TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20(5):271–274.CrossRefGoogle ScholarPubMed
3. Donetz, AP, Harvey, RA, Greco, RS. Stability of antibiotics bound to polytetrafluoroethylene with cationic surfactants. J Clin Microbiol 1984; 19(1):1–3.CrossRefGoogle ScholarPubMed
4. Hamilton, AJ, Orozco, J, Narotam, P, Bowersock, T. Efficacy of vancomycin/tri-iododecyclemethyl ammonium chloride-coated ventriculostomy catheters in reducing infection. Neurosurgery 1997; 40(5):1043–1049.CrossRefGoogle ScholarPubMed
5. Kamal, GD, Pfaller, MA, Rempe, LE, Jebson, PJ. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265(18):2364–2368.CrossRefGoogle ScholarPubMed
6. Raad, I, Darouiche, R, Dupuis, J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127(4):267–274.CrossRefGoogle ScholarPubMed
7. Friedman, WA, Vries, JK. Percutaneous tunnel ventriculostomy. Summary of 100 procedures. J Neurosurg 1980; 53(5):662–665.CrossRefGoogle ScholarPubMed
8. Gopinath, SP, Robertson, CS, Contant, CF, et al. Clinical evaluation of a miniature strain-gauge transducer for monitoring intracranial pressure. Neurosurgery 1995; 36(6):1137–1140.CrossRefGoogle ScholarPubMed
9. Aucoin, PJ, Kotilainen, HR, Gantz, NM, et al. Intracranial pressure monitors. Epidemiologic study of risk factors and infections. Am J Med 1986; 80(3):369–376.CrossRefGoogle ScholarPubMed
10. Blomstedt, GC. Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. A double-blind randomized trial. J Neurosurg 1985; 62(5):694–697.CrossRefGoogle ScholarPubMed
11. Blomstedt, GC. Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. A double-blind randomized trial. J Neurosurg 1985; 62(5):694–697.CrossRefGoogle ScholarPubMed
12. Zabramski, JM, Whiting, D, Darouiche, RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003; 98(4):725–730.CrossRefGoogle ScholarPubMed
13. Pearce, RS, West, LR, Rodeheaver, GT, Edlich, RF. Evaluation of a new hydrogel coating for drainage tubes. Am J Surg 1984; 148(5):687–691.CrossRefGoogle ScholarPubMed
14. Stenager, E, Gerner-Smidt, P, Kock-Jensen, C. Ventriculostomy-related infections - an epidemiological study. Acta Neurochir (Wien) 1986; 83(1-2):20–23.CrossRefGoogle ScholarPubMed
15. Chan, KH, Mann, KS. Prolonged therapeutic external ventricular drainage: a prospective study. Neurosurgery 1988; 23(4):436–438.CrossRefGoogle ScholarPubMed
16. Chaparro, MJ, Pritz, MB, Yonemura, KS. Broviac ventriculostomy for long-term external ventricular drainage. Pediatr Neurosurg 1991; 17(4):208–212.CrossRefGoogle ScholarPubMed
17. Mayhall, CG, Archer, NH, Lamb, VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med 1984; 310(9):553–559.Google ScholarPubMed
18. Holloway, KL, Barnes, T, Choi, S, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg 1996; 85(3):419–424.CrossRefGoogle ScholarPubMed
19. Darouiche, RO, Raad, II, Heard, SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340(1):1–8.CrossRefGoogle ScholarPubMed
20. Marik, PE, Abraham, G, Careau, P, Varon, J, Fromm, RE Jr. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999; 27(6):1128–1131.CrossRefGoogle ScholarPubMed
21. Trooskin, SZ, Donetz, AP, Baxter, J, Harvey, RA, Greco, RS. Infection-resistant continuous peritoneal dialysis catheters. Nephron 1987; 46(3):263–267.CrossRefGoogle ScholarPubMed
22. Alleyne, CH Jr, Hassan, M, Zabramski, JM. The efficacy and cost of prophylactic and perioprocedural antibiotics in patients with external ventricular drains. Neurosurgery 2000; 47(5):1124–1127.CrossRefGoogle ScholarPubMed
23. Aucoin, PJ, Kotilainen, HR, Gantz, NM, et al. Intracranial pressure monitors. Epidemiologic study of risk factors and infections. Am J Med 1986; 80(3):369–376.CrossRefGoogle ScholarPubMed
24. Kanter, RK, Weiner, LB, Patti, AM, Robson, LK. Infectious complications and duration of intracranial pressure monitoring. Crit Care Med 1985; 13(10):837–839.CrossRefGoogle ScholarPubMed
25. Sundbarg, G, Nordstrom, CH, Soderstrom, S. Complications due to prolonged ventricular fluid pressure recording. Br J Neurosurg 1988; 2(4):485–495.CrossRefGoogle ScholarPubMed
26. Trooskin, SZ, Donetz, AP, Harvey, RA, Greco, RS. Prevention of catheter sepsis by antibiotic bonding. Surgery 1985; 97(5):547–551.Google ScholarPubMed
27. Cook, AD, Sagers, RD, Pitt, WG. Bacterial adhesion to poly(HEMA)-based hydrogels. J Biomed Mater Res 1993; 27(1):119–126.CrossRefGoogle ScholarPubMed
28. Mayhall, CG, Archer, NH, Lamb, VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med 1984; 310(9):553–559.Google ScholarPubMed
29. Narayan, RK, Kishore, PR, Becker, DP, et al. Intracranial pressure: to monitor or not to monitor? A review of our experience with severe head injury. J Neurosurg 1982; 56(5):650–659.CrossRefGoogle ScholarPubMed
30. North, B, Reilly, P. Comparison among three methods of intracranial pressure recording. Neurosurgery 1986; 18(6):730–732.CrossRefGoogle ScholarPubMed
31. Paramore, CG, Turner, DA. Relative risks of ventriculostomy infection and morbidity. Acta Neurochir (Wien) 1994; 127(12):79–84.CrossRefGoogle Scholar
32. Kanter, RK, Weiner, LB, Patti, AM, Robson, LK. Infectious complications and duration of intracranial pressure monitoring. Crit Care Med 1985; 13(10):837–839.CrossRefGoogle ScholarPubMed
33. Levin, AB, Braun, SR, Grossman, JE. Physiological monitoring of the head-injured patient. Clin Neurosurg 1982; 29:240–287.CrossRefGoogle ScholarPubMed
34. Clark, WC, Muhlbauer, MS, Lowrey, R, et al. Complications of intracranial pressure monitoring in trauma patients. Neurosurgery 1989; 25(1):20–24.CrossRefGoogle ScholarPubMed
35. Wyler, AR, Kelly, WA. Use of antibiotics with external ventriculostomies. J Neurosurg 1972; 37(2):185–187.CrossRefGoogle ScholarPubMed
36. Yablon, JS, Lantner, HJ, McCormack, TM, et al. Clinical experience with a fiberoptic intracranial pressure monitor. J Clin Monit 1993; 9(3):171–175.CrossRefGoogle ScholarPubMed
37. Winfield, JA, Rosenthal, P, Kanter, RK, Casella, G. Duration of intracranial pressure monitoring does not predict daily risk of infectious complications. Neurosurgery 1993; 33(3):424–430.Google Scholar
38. Stenager, E, Gerner-Smidt, P, Kock-Jensen, C. Ventriculostomy-related infections - an epidemiological study. Acta Neurochir (Wien) 1986; 83(1-2):20–23.CrossRefGoogle ScholarPubMed
39. Sundbarg, G, Nordstrom, CH, Soderstrom, S. Complications due to prolonged ventricular fluid pressure recording. Br J Neurosurg 1988; 2(4):485–495.CrossRefGoogle ScholarPubMed
40. Schultz, M, Moore, K, Foote, AW. Bacterial ventriculitis and duration of ventriculostomy catheter insertion. J Neurosci Nurs 1993; 25(3):158–164.CrossRefGoogle ScholarPubMed
41. Smith, RW, Alksne, JF. Infections complicating the use of external ventriculostomy. J Neurosurg 1976; 44(5):567–570.CrossRefGoogle ScholarPubMed
42. Ropper, AH, Shafran, B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 1984; 41(1):26–29.CrossRefGoogle ScholarPubMed
43. Rosner, MJ, Becker, DP. ICP monitoring: complications and associated factors. Clin Neurosurg 1976; 23:494–519.CrossRefGoogle ScholarPubMed